Irish Life Investment Managers’s Genomic Health, Inc. GHDX Stock Holding History

Irish Life Investment Managers’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$29.4K	Buy	+927	New	+$30.4K	﹤0.01%	1748

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICM

IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Irish Life Investment Managers's GHDX Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Genomic Health, Inc. (GHDX) in Q2 2013: 927 shares worth $29.4K. The stake represents ﹤0.01% of the portfolio and ranks #1748 among its holdings.

115 funds tracked by Wall St. Rank hold GHDX as of Q2 2013.

Irish Life Investment Managers held 927 shares of Genomic Health, Inc. worth $29.4K as of Q2 2013.
Genomic Health, Inc. was a new Irish Life Investment Managers position in Q2 2013.
Genomic Health, Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1748 holding.
115 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.